Tuberculosis, immunology and microbiology. The PPE-guy. Preclinical lead TB vaccine development at BioNTech. Activity here strictly personal.
Louis Ates
Loading...
Oh wow, amazing: "Discovery and identification of a handwritten laboratory notebook by Albert Calmette and Camille Guérin describing experimental studies and development of the BCG vaccine for tuberculosis at the Institut Pasteur" doi.org/10.1016/j.tu...
I was discouraged when my "fish on bicycles" project failed to achieve its aims, but I can finally announce that I have completed my "FISH ON STILTS" project successfully.
Meet Bathypterois grallator, the tripod fish. They live in the deepest parts of the ocean, resting on three modified fins.
shocking statistics, but only limited public outcry.. We should be more vocal about this
tb.impactcounter.com
Spotted on a Thermo poster at #asms2026... Made me laugh
This is worth the click. I promise. Very well written indeed. ><
It is so great after 1+ year of tendonitis knee injury to be back on the ultimate frisbee pitch. Old dog still has some tricks up the sleeve. Footage from ulti.tv. #worklifebalance
I'm incredibly proud to share our paper on the preclinical evaluation of the BNT164 mRNA tuberculosis vaccine candidates.
Now online in the final version at Nature Immunology.
www.nature.com/articles/s41...
I am skeptical that already approved Ebola virus vaccines and monoclonals will show promise during the ongoing outbreak of Bundibugyo virus for the simple reason that the two viruses are highly divergent (~35% AA divergence in GP).
Focus should be on BDBV-specific or "pan-Ebola" countermeasures.
🧵
Clycstictyrinty is my favorite antibody mediated function! Maybe with some extra AI we can leverage it?!
After a long hiatus, happy #MicroscopyMonday! Here are some amoebae squeezing themselves into narrow channels (part of a video for our preprint pubmed.ncbi.nlm.nih.gov/41377514/).
Sound effects by Dillon (my 4 month old who may have had a little to do with the bluesky hiatus!)
Video
Video
Here the authors characterize mRNA-based tuberculosis vaccine candidates BNT164a1 and BNT164b1 and show that they are immunogenic, well tolerated and efficacious in preclinical animal models.
"It’s worth doing a clinical study, but I think the idea that, like, ‘Oh, let’s just roll out Ervebo and then hope for the best’ is misguided."
cen.acs.org/articles/104...
ROCKVILLE, MD—The Biophysical Society confirmed Tuesday that it has spent its entire $14,000 annual advertising budget on a single advertisement on the side of a Washington, D.C., Metrobus that reads…
Review: A new era of NK cell immunotherapy in tumor treatment: latest advances and cutting-edge perspectives from basic research to clinical practice
www.frontiersin.org/journals/imm... @frontiersin.bsky.social
